Weidemann F, Breunig F, Beer M, Sandstede J, Störk S, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM (2005) The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur Heart J 26:1221–1227. https://doi.org/10.1093/eurheartj/ehi143
Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, Elliott PM, Hagege A, Kuusisto J, Linhart A, Nordbeck P, Olivotto I, Pietilä-Effati P, Namdar M (2021) Cardiac involvement in Fabry disease: JACC review topic of the week. J Am Coll Cardiol 77:922–936. https://doi.org/10.1016/j.jacc.2020.12.024
Article CAS PubMed Google Scholar
Mehta A, Clarke JT, Giugliani R, Elliott P, Linhart A, Beck M, Sunder-Plassmann G, Investigators FOS (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry outcome survey. J Med Genet 46:548–552. https://doi.org/10.1136/jmg.2008.065904
Article CAS PubMed Google Scholar
Orsborne C, Bradley J, Bonnett LJ, Pleva LA, Naish JH, Clark DG, Abidin N, Woolfson P, Nucifora G, Schmitt M, Jovanovic A, Miller CA, Reid AB (2022) Validated model for prediction of adverse cardiac outcome in patients with Fabry disease. J Am Coll Cardiol 80:982–994. https://doi.org/10.1016/j.jacc.2022.06.022
Nordin S, Kozor R, Medina-Menacho K, Abdel-Gadir A, Baig S, Sado DM, Lobascio I, Murphy E, Lachmann RH, Mehta A, Edwards NC, Ramaswami U, Steeds RP, Hughes D, Moon JC (2019) Proposed stages of myocardial phenotype development in Fabry disease. JACC Cardiovasc Imaging 12:1673–1683. https://doi.org/10.1016/j.jcmg.2018.03.020
Echevarria L, Benistan K, Toussaint A, Dubourg O, Hagege AA, Eladari D, Jabbour F, Beldjord C, De Mazancourt P, Germain DP (2016) X-chromosome inactivation in female patients with Fabry disease. Clin Genet 89:44–54. https://doi.org/10.1111/cge.12613
Article CAS PubMed Google Scholar
Germain DP, Elliott PM, Falissard B, Fomin VV, Hilz MJ, Jovanovic A, Kantola I, Linhart A, Mignani R, Namdar M, Nowak A, Oliveira JP, Pieroni M, Viana-Baptista M, Wanner C, Spada M (2019) The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts. Mol Genet Metab Rep 19:100454. https://doi.org/10.1016/j.ymgmr.2019.100454
Article CAS PubMed PubMed Central Google Scholar
Meucci MC, Lillo R, Del Franco A, Monda E, Iannaccone G, Baldassarre R, Di Nicola F, Parisi V, Lombardo A, Spinelli L, Biagini E, Pieroni M, Pisani A, Crea F, Iaccarino G, Limongelli G, Olivotto I, Graziani F (2023) Prognostic implications of the extent of cardiac damage in patients with Fabry disease. J Am Coll Cardiol 82:1524–1534. https://doi.org/10.1016/j.jacc.2023.07.02
Olivotto I, Cecchi F, Poggesi C, Yacoub MH (2012) Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail 5:535–546. https://doi.org/10.1161/CIRCHEARTFAILURE.112.967026
Wilson HC, Hopkin RJ, Madueme PC, Czosek RJ, Bailey LA, Taylor MD, Jefferies JL (2017) Arrhythmia and clinical cardiac findings in children with Anderson-Fabry disease. Am J Cardiol 120:251–255. https://doi.org/10.1016/j.amjcard.2017.04.016
Hernández-Hernández A, Diez-López C, Azevedo O, Palomino-Doza J, Alfonso F, Fuentes-Cañamero ME, Mogollón Jiménez MV, Casanova Rodríguez C, Ruz A, Tirón C, Climent V, Garcia-Pavia P (2021) Screening of Fabry disease in patients with chest pain without obstructive coronary artery disease. J Cardiovasc Transl Res 14:948–950. https://doi.org/10.1007/s12265-020-10097-2
Kitani Y, Nakagawa N, Sakamoto N, Takeuchi T, Takahashi F, Momosaki K, Nakamura K, Endo F, Maruyama H, Hasebe N (2019) Unexpectedly high prevalence of coronary spastic angina in patients with Anderson-Fabry disease. Circ J 83:481–484. https://doi.org/10.1253/circj.CJ-18-0734
Chimenti C, Morgante E, Tanzilli G, Mangieri E, Critelli G, Gaudio C, Russo MA, Frustaci A (2008) Angina in Fabry disease reflects coronary small vessel disease. Circ Heart Fail 1:161–169. https://doi.org/10.1161/CIRCHEARTFAILURE.108.769729
Coughlan JJ, Elkholy K, O'Brien J, Kiernan T (2016) Atypical patterns of cardiac involvement in Fabry disease. BMJ Case Rep 2016:bcr2015213819. https://doi.org/10.1136/bcr-2015-213819
Graziani F, Lillo R, Panaioli E, Spagnoletti G, Bruno I, Leccisotti L, Marano R, Manna R, Crea F (2019) Massive coronary microvascular dysfunction in severe Anderson-Fabry disease cardiomyopathy. Circ Cardiovasc Imaging 12:e009104. https://doi.org/10.1161/CIRCIMAGING.119.009104
Elliott PM, Kindler H, Shah JS, Sachdev B, Rimoldi OE, Thaman R, Tome MT, McKenna WJ, Lee P, Camici PG (2006) Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A. Heart 92:357–360. https://doi.org/10.1136/hrt.2004.054015
Article CAS PubMed Google Scholar
Roy A, Umar H, Ochoa-Ferraro A, Warfield A, Lewis N, Geberhiwot T, Steeds R (2021) Atherosclerosis in Fabry disease-a contemporary review. J Clin Med 10:4422. https://doi.org/10.3390/jcm10194422
Article CAS PubMed PubMed Central Google Scholar
Zhou S, Wang X, Xu H, Li J, Zhang L, Li H (2022) Fabry disease with acute myocardial infarction, left ventricular thrombosis, and pericardial effusion: a case report. Medicine (Baltimore) 101:e29427. https://doi.org/10.1097/MD.0000000000029427
Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, Elliott PM, European FOS investigators (2007) Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28:1228–1235. https://doi.org/10.1093/eurheartj/ehm153
Graziani F, Lillo R, Panaioli E, Spagnoletti G, Pieroni M, Ferrazzi P, Camporeale A, Verrecchia E, Sicignano LL, Manna R, Crea F (2021) Evidence of evolution towards left midventricular obstruction in severe Anderson-Fabry cardiomyopathy. ESC Heart Fail 8:725–728. https://doi.org/10.1002/ehf2.13101
Zemánek D, Marek J, Dostálová G, Magage S, Roblová L, Kovárník T, Linhart A (2021) Usefulness of alcohol septal ablation in the left ventricular outflow tract obstruction in Fabry disease cardiomyopathy. Am J Cardiol 150:110–113. https://doi.org/10.1016/j.amjcard.2021.03.042
Article CAS PubMed Google Scholar
Meghji Z, Nguyen A, Miranda WR, Geske JB, Schaff HV, Peck DS, Newman DB (2019) Surgical septal myectomy for relief of dynamic obstruction in Anderson-Fabry disease. Int J Cardiol 292:91–94. https://doi.org/10.1016/j.ijcard.2019.06.042
Efthimiou J, McLelland J, Betteridge DJ (1986) Short PR intervals and tachyarrhythmias in Fabry’s disease. Postgrad Med J 62:285–287. https://doi.org/10.1136/pgmj.62.726.285
Article CAS PubMed PubMed Central Google Scholar
Chimenti C, Russo MA, Frustaci A (2010) Atrial biopsy evidence of Fabry disease causing lone atrial fibrillation. Heart 96:1782–1783. https://doi.org/10.1136/hrt.2010.196162
Article CAS PubMed Google Scholar
Kim H, Kang MG, Park HW, Park JR, Hwang JY, Kim K (2021) Anderson-Fabry disease presenting with atrial fibrillation as earlier sign in a young patient: a case report. World J Clin Cases 9:4823–4828. https://doi.org/10.12998/wjcc.v9.i18.4823
Qian P, Ross D, Tchan M, Sadick N (2015) A patient with recurrent disabling atrial fibrillation and Fabry cardiomyopathy successfully treated with single ring pulmonary vein isolation. Int J Cardiol 182:375–376. https://doi.org/10.1016/j.ijcard.2015.01.001
Weidemann F, Maier SK, Störk S, Brunner T, Liu D, Hu K, Seydelmann N, Schneider A, Becher J, Canan-Kühl S, Blaschke D, Bijnens B, Ertl G, Wanner C, Nordbeck P (2016) Usefulness of an implantable loop recorder to detect clinically relevant arrhythmias in patients with advanced Fabry cardiomyopathy. Am J Cardiol 118:264–274. https://doi.org/10.1016/j.amjcard.2016.04.033
Pavlu L, Kocourkova L, Taborsky M, Petrkova J (2018) Ventricular tachycardia: a presentation of Fabry disease case report. Eur Heart J Case Rep 3:yty154. https://doi.org/10.1093/ehjcr/yty154
Hanneman K, Karur GR, Wasim S, Wald RM, Iwanochko RM, Morel CF (2020) Left ventricular hypertrophy and late gadolinium enhancement at cardiac MRI are associated with adverse cardiac events in Fabry disease. Radiology 294:42–49. https://doi.org/10.1148/radiol.2019191385
Silva-Gburek J, Rochford L, Hopkin R, Jefferies JL (2016) Ventricular tachycardia in Fabry disease detected in a 50-year-old woman during 14-day continuous cardiac monitoring. Tex Heart Inst J 43:531–533. https://doi.org/10.14503/THIJ-15-5572
Ditac G, Gardey K, Jobbé-Duval A, Fouilhoux A, Millat G, Chevalier P (2021) Late-onset Fabry disease revealed by ventricular tachycardia: a case report. HeartRhythm Case Rep 8:79–83. https://doi.org/10.1016/j.hrcr.2021.11.025
Article PubMed PubMed Central Google Scholar
Mills MT, Nelson TA, Kelland NF, Sahu J, Lee J, Lewis N, Hiwot T, Kyriacou AL (2021) Radiofrequency ablation of ventricular tachycardia in Anderson-Fabry disease: a case series. Eur Heart J Case Rep 5:ytaa529. https://doi.org/10.1093/ehjcr/ytaa529
Baig S, Edward NC, Kotecha D, Liu B, Nordin S, Kozor R, Moon JC, Geberhiwot T, Steeds RP (2018) Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice. Europace 20:f153–f161. https://doi.org/10.1093/europace/eux261
Sené T, Lidove O, Sebbah J, Darondel JM, Picard H, Aaron L, Fain O, Zenone T, Joly D, Charron P, Ziza JM (2016) Cardiac device implantation in Fabry disease: a retrospective monocentric study. Medicine (Baltimore) 95:e4996. https://doi.org/10.1097/MD.0000000000004996
Suzuki M, Goto T, Kato R, Yamauchi K, Hayashi H (1990) Combined atrioventricular block and sinus node dysfunction in Fabry’s disease. Am Heart J 120:438–440. https://doi.org/10.1016/0002-8703(90)90096-g
Article CAS PubMed Google Scholar
Jastrzebski M, Bacior B, Dimitrow PP, Kawecka-Jaszcz K (2006) Electrophysiological study in a patient with Fabry disease and a short PQ interval. Europace 8:1045–1047.
Comments (0)